Abstract
Viral infections remain a major cause of morbidity and mortality after pediatric hematopoietic stem cell transplantation. Adoptive transfer of donor-derived virus-specific T cells can reconstitute antiviral immunity in recipients and be effective both in preventing and treating cytomegalovirus, Epstein-Barr virus and adenovirus infection. Current efforts are focused on providing protection toward a broader range of viruses safely, rapidly and effectively.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 193-198 |
| Number of pages | 6 |
| Journal | Bone Marrow Transplantation |
| Volume | 41 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 2008 |
ASJC Scopus subject areas
- Hematology
- Transplantation